Physician profile
Stephen Snell
NPI 1083616247
$3,506.04
in general payments reported to CMS, 2019-2025
25 companies · $699 in 2025
The $699 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $446 · 2021: $596 · 2022: $539 · 2023: $455 · 2024: $640 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,314 · Education: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.64 |
| Education | $479.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,283.07 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $828.52 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $443.67 | 2023-2025 | Lumryz |
| Optinose US, INC. | $181.88 | 2020-2022 | |
| Kaleo, INC. | $132.65 | 2019-2023 | Auvi-Q |
| Fisher & Paykel Healthcare INC | $81.77 | 2019-2024 | Fisher & Paykel Healthcare |
| Glaxosmithkline, LLC. | $73.30 | 2023-2025 | Nucala |
| Stryker Corporation | $65.45 | 2021-2025 | Xpress Loprofile |
| Sanofi-Aventis U.S. LLC | $50.99 | 2020-2021 | |
| Genzyme Corporation | $49.29 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $38.48 | 2025 | Neffy |
| Philips North America LLC | $32.15 | 2019 | |
| Eisai INC. | $31.81 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $27.62 | 2021 | |
| Alk-Abello, INC | $26.38 | 2023 | Ragwitek, Odactra, Grastek |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $19.34 | 2021 | |
| Greer Laboratories, INC. | $18.61 | 2025 | Oralair |
| Olympus America INC. | $18.46 | 2024 | Rhino-Laryngo Videoscope |
| Axsome Therapeutics, INC. | $18.43 | 2023 | Sunosi |
| Cook Medical LLC | $17.24 | 2023 | Biodesign |
| Preceptis Medical, INC. | $15.65 | 2024 | Hummingbird Tympanostomy Tube System |
| Omeros Corporation | $13.60 | 2019 | |
| Smith+Nephew, INC. | $12.94 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.77 | 2021 | |
| Medtronic, INC. | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Snell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.